Peer Reviewed
Feature Article Infectious diseases

Influenza: developments in its prevention and control

Alan W Hampson
Recent efforts to lessen the impact of influenza have followed three approaches: increased use of existing vaccines, development of new vaccines and specific antiviral therapy. The current status of these efforts is reviewed.
Key Points
  • Influenza continues to be a major public health problem, having its greatest impact on the elderly and on people with underlying medical conditions.
  • Vaccines prepared from inactivated influenza virus have been available for more than half a century, but their use has only become widely accepted during the last 10 to 15 years.
  • A recent Australian survey found that only 32% of people aged 40 to 64 years who were at risk of complications of influenza were vaccinated annually.
  • Clinical diagnosis of influenza is difficult due to the variability of symptoms and clinical similarity of other infections such as that due to respiratory syncytial virus.
  • Two new drugs, zanamivir and oseltamivir, have been shown to be beneficial in the treatment of influenza if administered early in the course of the infection.
Purchase the PDF version of this article
Already a subscriber?